US4885249A
(en)
*
|
1984-12-05 |
1989-12-05 |
Allelix, Inc. |
Aspergillus niger transformation system
|
US5198345A
(en)
*
|
1985-04-15 |
1993-03-30 |
Gist-Brocades N.V. |
Vectors in use in filamentous fungi
|
US5766912A
(en)
*
|
1986-03-17 |
1998-06-16 |
Novo Nordisk A/S |
Humicola lipase produced in aspergillus
|
US5536661A
(en)
*
|
1987-03-10 |
1996-07-16 |
Novo Nordisk A/S |
Process for the production of protein products in aspergillus
|
US5447862A
(en)
*
|
1987-02-04 |
1995-09-05 |
Ciba-Geigy Corporation |
Pectin lyase genes of aspergillus niger
|
US5610034A
(en)
*
|
1987-04-29 |
1997-03-11 |
Alko Group Ltd. |
Immunoglobulin production by trichoderma
|
US5849881A
(en)
*
|
1989-05-05 |
1998-12-15 |
Baylor College Medicine |
Production of recombinant lactoferrin and lactoferrin polypeptides using cDNA sequences in various organisms
|
IL97311A0
(en)
*
|
1990-02-23 |
1992-05-25 |
Lilly Co Eli |
Vectors and compounds for expression of glycosylation mutants of human protein c
|
IL97312A
(en)
*
|
1990-02-23 |
1999-01-26 |
Lilly Co Eli |
Method for producing a polypeptide in a eukaryotic host cell and recombinant dna vectors containing an improved transcription control unit based on the adenovirus 2 major late promoter used thereto
|
CA2097180C
(en)
*
|
1990-12-10 |
2007-08-14 |
Timothy Fowler |
Saccharification of cellulose by cloning and amplification of the .beta.-glucosidase gene of trichoderma reesei
|
US5997913A
(en)
*
|
1990-12-10 |
1999-12-07 |
Genencor International, Inc. |
Method enhancing flavor and aroma in foods by overexpression of β-glucosidase
|
US5834262A
(en)
*
|
1992-01-06 |
1998-11-10 |
E. I. Du Pont De Nemours And Company |
Oxidation of glycolic acid to glyoxylic acid using a microbial cell transformant as catalyst
|
ZA932568B
(en)
*
|
1992-04-24 |
1993-11-12 |
Baylor College Midecine A Non |
Production of recombinant human lactoferrin
|
US5541094A
(en)
*
|
1992-09-25 |
1996-07-30 |
E. I. Du Pont De Nemours And Company |
Glyoxylic acid/aminomethylphosphonic acid mixtures prepared using a microbial transformant
|
US5683899A
(en)
*
|
1994-02-03 |
1997-11-04 |
University Of Hawaii |
Methods and compositions for combinatorial-based discovery of new multimeric molecules
|
US6268140B1
(en)
|
1994-02-03 |
2001-07-31 |
Neugenesis |
Combinatorial metabolic libraries
|
US5643745A
(en)
*
|
1994-02-03 |
1997-07-01 |
University Of Hawaii |
Heterologous dimeric proteins produced in heterokaryons
|
CN101659926A
(en)
*
|
1994-06-30 |
2010-03-03 |
诺沃奇梅兹有限公司 |
Non-toxic, non-toxigenic, non-pathogenic fusarium expression system and promoters and terminators for use therein
|
US5608145A
(en)
|
1994-08-23 |
1997-03-04 |
The Regents Of The University Of California |
High-affinity potassium uptake transporter from higher plants
|
CN101173263A
(en)
|
1995-03-17 |
2008-05-07 |
诺沃奇梅兹有限公司 |
Novel endoglucanases
|
JPH0993422A
(en)
*
|
1995-09-28 |
1997-04-04 |
Fujitsu Ltd |
Image processor for correcting image frame of compression object image and its method
|
US5776730A
(en)
*
|
1995-12-15 |
1998-07-07 |
University Of Hawaii |
Neurospora hosts for the production of recombinant proteins, and methods for producing same
|
DE69717092T2
(en)
|
1996-03-01 |
2003-07-24 |
Novo Nordisk As |
Use of a pharmaceutical composition containing an appetite suppressing peptide
|
US7883872B2
(en)
*
|
1996-10-10 |
2011-02-08 |
Dyadic International (Usa), Inc. |
Construction of highly efficient cellulase compositions for enzymatic hydrolysis of cellulose
|
US5811381A
(en)
*
|
1996-10-10 |
1998-09-22 |
Mark A. Emalfarb |
Cellulase compositions and methods of use
|
ATE318906T1
(en)
|
1996-10-16 |
2006-03-15 |
Zymogenetics Inc |
FIBROBLAST GROWTH FACTORS HOMOLOGOFIBROBLAST GROWTH FACTORS HOMOLOGOUS
|
ATE374247T1
(en)
|
1997-10-14 |
2007-10-15 |
Darwin Molecular Corp |
THYMIDINE KINASE MUTANTS AND FUSION PROTEINS WITH THYMIDINE KINASE AND GUANYLATE KINASE ACTIVITIES
|
EA201001190A1
(en)
|
1998-09-23 |
2011-04-29 |
Займодженетикс, Инк. |
ISOLATED ANTIBODY, SPECIFICALLY ASSOCIATED WITH POLYPEPTIDE, CONTAINING FROM THE SEQUENCE OF AMINO ACID RESIDUES
|
DK1117808T3
(en)
*
|
1998-10-06 |
2005-04-25 |
Mark Aaron Emalfarb |
Transformational system before comparing the area of filamentous fungal hosts: In the chrysosporium
|
DE69942782D1
(en)
|
1998-11-27 |
2010-10-28 |
Ucb Sa |
Compositions and methods for increasing bone mineralization
|
US20040009535A1
(en)
|
1998-11-27 |
2004-01-15 |
Celltech R&D, Inc. |
Compositions and methods for increasing bone mineralization
|
DK1137773T3
(en)
|
1998-12-07 |
2008-12-08 |
Zymogenetics Inc |
Liquid Factor Homolog ZVEGF3
|
US7063850B1
(en)
*
|
1998-12-22 |
2006-06-20 |
University Of Tennessee Research Foundation |
Protective antigen of group A Streptococci
|
ES2329254T3
(en)
|
1999-01-07 |
2009-11-24 |
Zymogenetics, Inc. |
THERAPEUTIC USES OF BR43X2 SOLUBLE RECEIVERS.
|
US7833529B1
(en)
|
1999-01-07 |
2010-11-16 |
Zymogenetics, Inc. |
Methods for inhibiting B lymphocyte proliferation with soluble ztnf4 receptor
|
CN101575377B
(en)
|
1999-03-09 |
2012-12-26 |
津莫吉尼蒂克斯公司 |
Human cytokine as ligand of zalpha receptor and use thereof
|
EP1860188B1
(en)
|
1999-07-07 |
2011-05-04 |
ZymoGenetics, Inc. |
Human cytokine receptor
|
ATE459716T1
(en)
|
1999-12-23 |
2010-03-15 |
Zymogenetics Inc |
CYTOKINE ZCYT018
|
WO2001087933A2
(en)
|
2000-05-11 |
2001-11-22 |
Zymogenetics, Inc. |
Zsig33-like peptides
|
DK1325115T3
(en)
|
2000-06-26 |
2016-11-21 |
Zymogenetics Inc |
CYTOKINRECEPTOR ZCYTOR17
|
US7598055B2
(en)
|
2000-06-28 |
2009-10-06 |
Glycofi, Inc. |
N-acetylglucosaminyltransferase III expression in lower eukaryotes
|
US8697394B2
(en)
*
|
2000-06-28 |
2014-04-15 |
Glycofi, Inc. |
Production of modified glycoproteins having multiple antennary structures
|
EP2322644A1
(en)
*
|
2000-06-28 |
2011-05-18 |
GlycoFi, Inc. |
Methods for producing modified glycoproteins
|
US7863020B2
(en)
*
|
2000-06-28 |
2011-01-04 |
Glycofi, Inc. |
Production of sialylated N-glycans in lower eukaryotes
|
US7449308B2
(en)
|
2000-06-28 |
2008-11-11 |
Glycofi, Inc. |
Combinatorial DNA library for producing modified N-glycans in lower eukaryotes
|
US7625756B2
(en)
|
2000-06-28 |
2009-12-01 |
GycoFi, Inc. |
Expression of class 2 mannosidase and class III mannosidase in lower eukaryotic cells
|
ES2311253T3
(en)
|
2000-06-30 |
2009-02-01 |
Zymogenetics, Inc. |
ALELIC VARIANTE OF AN INTERFERON TYPE ZCYT021 PROTEIN.
|
EP1736545A3
(en)
|
2000-08-08 |
2007-03-28 |
ZymoGenetics, Inc. |
Soluble zcytor 11 cytokine receptors
|
EP2301971A1
(en)
|
2001-02-20 |
2011-03-30 |
ZymoGenetics, L.L.C. |
Antibodies that bind both BCMA and TACI
|
ES2432967T3
(en)
|
2001-03-22 |
2013-12-05 |
Novo Nordisk Health Care Ag |
Coagulation Factor VII derivatives
|
DE60228477D1
(en)
|
2001-05-08 |
2008-10-02 |
Darwin Molecular Corp |
PROCESS FOR REGULATING THE IMMUNE FUNCTION IN PRIMATES USING THE FOXP3 PROTEIN
|
EP1436003B3
(en)
|
2001-05-24 |
2012-03-14 |
ZymoGenetics, Inc. |
Taci-immunoglobulin fusion proteins
|
WO2002094871A1
(en)
|
2001-05-24 |
2002-11-28 |
Human Dna Technology Inc |
Novel keratinocyte growth factor-2 analogue in hair follicle
|
ES2606840T3
(en)
|
2001-10-10 |
2017-03-28 |
Ratiopharm Gmbh |
Remodeling and glycoconjugation of granulocyte colony stimulating factor (G-CSF)
|
DK2279755T3
(en)
|
2001-10-10 |
2014-05-26 |
Ratiopharm Gmbh |
Remodeling and glycoconjugation of fibroblast growth factor (FGF)
|
US6939959B2
(en)
*
|
2001-10-26 |
2005-09-06 |
Id Biomedical Corporation Of Washington |
Efficient protein expression system
|
DK1451322T3
(en)
|
2001-11-05 |
2010-02-01 |
Zymogenetics Inc |
IL-21 antagonists
|
WO2003057179A2
(en)
|
2002-01-11 |
2003-07-17 |
Biomarin Pharmaceutical, Inc. |
Use of p97 as an enzyme delivery system for the delivery of therapeutic lysosomal enzymes
|
ES2351678T3
(en)
|
2002-01-18 |
2011-02-09 |
Zymogenetics, Inc. |
BINDING CITOCINE FOR THE TREATMENT OF ASTHMA AND HYPER-SENSITIVITY OF RESPIRATORY ROUTES.
|
EP2840089A1
(en)
|
2002-01-18 |
2015-02-25 |
ZymoGenetics, Inc. |
Cytokine receptor zcytor17 multimers
|
AU2003206684A1
(en)
*
|
2002-02-20 |
2003-09-09 |
Novozymes A/S |
Plant polypeptide production
|
CN101676728A
(en)
|
2002-04-19 |
2010-03-24 |
津莫吉尼蒂克斯公司 |
cytokine receptor
|
US20060005282A1
(en)
*
|
2002-04-23 |
2006-01-05 |
Activx Biosciences, Inc |
Production and use of salt tolerant and culture density tolerant organisms
|
WO2004009838A2
(en)
|
2002-07-23 |
2004-01-29 |
Neose Technologies, Inc. |
H. Pylori FUCOSYLTRANSFERASES
|
US7332299B2
(en)
|
2003-02-20 |
2008-02-19 |
Glycofi, Inc. |
Endomannosidases in the modification of glycoproteins in eukaryotes
|
US20070026485A1
(en)
|
2003-04-09 |
2007-02-01 |
Neose Technologies, Inc. |
Glycopegylation methods and proteins/peptides produced by the methods
|
CA2534907C
(en)
|
2003-08-07 |
2014-04-29 |
Zymogenetics, Inc. |
Homogeneous preparations of il-28 and il-29
|
JP4824559B2
(en)
|
2003-09-09 |
2011-11-30 |
ノボ ノルディスク ヘルス ケア アクチェンゲゼルシャフト |
Coagulation factor VII polypeptide
|
JP4359286B2
(en)
*
|
2003-10-31 |
2009-11-04 |
ピレリ・タイヤ・ソチエタ・ペル・アツィオーニ |
Inflatable bladder for tire vulcanizer, method for producing the same, and process for producing tires for wheels
|
KR101348530B1
(en)
*
|
2003-11-06 |
2014-02-14 |
다니스코 유에스 인크. |
Expression in filamentous fungi of protease inhibitors and variants thereof
|
ATE516349T1
(en)
|
2004-02-04 |
2011-07-15 |
Novo Nordisk As |
METHOD FOR REFOLDING MAMMAL GLYCOSYL TRANSFERASES
|
CN1942584B
(en)
|
2004-02-13 |
2011-07-27 |
诺维信公司 |
Protease variants
|
US7381794B2
(en)
|
2004-03-08 |
2008-06-03 |
Zymogenetics, Inc. |
Dimeric fusion proteins and materials and methods for producing them
|
AU2005266892B2
(en)
|
2004-07-29 |
2011-03-03 |
Bristol-Myers Squibb Company |
Use of IL-28 and IL-29 to treat cancer and autoimmune disorders
|
CN101001951B
(en)
|
2004-08-02 |
2011-06-15 |
巴斯福植物科学有限公司 |
Method for isolation of transcription termination sequences
|
DK1799261T3
(en)
|
2004-10-15 |
2013-03-11 |
Intrexon Corp |
Methods and compositions for combinatorial production of multivalent recombinant antigens
|
AU2006212807A1
(en)
|
2005-02-08 |
2006-08-17 |
Zymogenetics, Inc. |
Anti-IL-20, anti-IL-22 and anti-IL-22RA antibodies and binding partners and methods of using in inflammation
|
EP2360181B1
(en)
|
2005-04-18 |
2013-09-18 |
Novo Nordisk A/S |
IL-21 variants
|
WO2006124667A2
(en)
|
2005-05-12 |
2006-11-23 |
Zymogenetics, Inc. |
Compositions and methods for modulating immune responses
|
WO2006130657A2
(en)
*
|
2005-05-31 |
2006-12-07 |
Bristol-Myers Squibb Company |
Stereoselective reduction process for the preparation of pyrrolotriazine compounds
|
US7820422B2
(en)
*
|
2005-06-16 |
2010-10-26 |
Centre National De La Recherche Scientifique (Cnrs) |
Efficient production of oligosaccharides using metabolically engineered microorganisms
|
KR20080056714A
(en)
*
|
2005-08-09 |
2008-06-23 |
지모제넥틱스, 인코포레이티드 |
Methods for treating b-cell malignancies using taci-ig fusion molecule
|
WO2007019573A2
(en)
|
2005-08-09 |
2007-02-15 |
Zymogenetics, Inc. |
Methods for the treatment and prevention of abnormal cell proliferation using taci-fusion molecules
|
US20090055942A1
(en)
|
2005-09-14 |
2009-02-26 |
Novo Nordisk Healthcare A/G |
Human Coagulation Factor VII Polypeptides
|
US7855279B2
(en)
|
2005-09-27 |
2010-12-21 |
Amunix Operating, Inc. |
Unstructured recombinant polymers and uses thereof
|
EP1931697B1
(en)
|
2005-09-28 |
2010-09-15 |
ZymoGenetics, Inc. |
Il-17a and il-17f antagonists and methods of using the same
|
EP2035028A2
(en)
*
|
2006-05-15 |
2009-03-18 |
Ares Trading S.A. |
Methods for treating autoimmune diseases using a taci-ig fusion molecule
|
KR20150038558A
(en)
|
2006-11-30 |
2015-04-08 |
탭이뮨, 인크. |
Poxviridae treatment comprising TAP-1 and/or TAP-2 as a molecular adjuvant
|
US9862956B2
(en)
|
2006-12-10 |
2018-01-09 |
Danisco Us Inc. |
Expression and high-throughput screening of complex expressed DNA libraries in filamentous fungi
|
WO2008073914A2
(en)
|
2006-12-10 |
2008-06-19 |
Dyadic International Inc. |
Expression and high-throughput screening of complex expressed dna libraries in filamentous fungi
|
WO2008157263A2
(en)
|
2007-06-15 |
2008-12-24 |
Arkansas State University |
Methods of delivery of molecules to cells using a ricin subunit and compositions relating to same
|
EP2197893B1
(en)
*
|
2007-09-07 |
2013-07-24 |
Dyadic International, Inc. |
Novel fungal enzymes
|
CN103059118B
(en)
|
2007-11-21 |
2017-11-24 |
罗斯基勒大学 |
Polypeptide with ice-binding activity
|
WO2009080054A1
(en)
*
|
2007-12-21 |
2009-07-02 |
Ifxa A/S |
Protease inhibitor
|
US8653020B2
(en)
*
|
2008-01-25 |
2014-02-18 |
Aarhus Universitet |
Selective exosite inhibition of PAPP-A activity against IGFBP-4
|
WO2009120922A2
(en)
|
2008-03-27 |
2009-10-01 |
Zymogenetics, Inc. |
Compositions and methods for inhibiting pdgfrbeta and vegf-a
|
EP2623112B1
(en)
|
2008-06-27 |
2015-03-04 |
Zymogenetics, Inc. |
Soluble hybrid Fc gamma receptors and related methods
|
MX2011006483A
(en)
|
2008-12-16 |
2011-07-13 |
Novartis Ag |
Yeast display systems.
|
PT2393828T
(en)
|
2009-02-03 |
2017-01-18 |
Amunix Operating Inc |
Extended recombinant polypeptides and compositions comprising same
|
US20120107267A1
(en)
|
2009-03-11 |
2012-05-03 |
Novo Nordisk A/S |
Interleukin-21 variants having antagonistic binding to the il-21 receptor
|
WO2011006982A2
(en)
|
2009-07-17 |
2011-01-20 |
Rigshospitalet |
Inhibitors of complement activation
|
JP5813641B2
(en)
|
2009-08-24 |
2015-11-17 |
アムニクス オペレーティング インコーポレイテッド |
Coagulation factor IX composition and methods of making and using the same
|
JP5931738B2
(en)
|
2009-12-01 |
2016-06-08 |
ノヴォ ノルディスク アー/エス |
Novel peptidyl alpha-hydroxyglycine alpha-amidated lyase
|
JP6148013B2
(en)
|
2010-03-05 |
2017-06-14 |
リグショスピタレト |
Chimera inhibitor molecule of complement activation
|
WO2011156356A1
(en)
|
2010-06-09 |
2011-12-15 |
Zymogenetics, Inc. |
Dimeric vstm3 fusion proteins and related compositions and methods
|
CA2833176C
(en)
|
2011-04-12 |
2023-05-16 |
C.B. Appaiah |
Chimeric antibacterial polypeptides
|
CN103747807B
(en)
|
2011-07-05 |
2016-12-07 |
比奥阿赛斯技术有限公司 |
P97 antibody conjugates and using method
|
EP3321281B1
(en)
|
2011-08-05 |
2019-11-27 |
biOasis Technologies Inc |
P97 fragments with transfer activity
|
KR102007054B1
(en)
|
2011-09-12 |
2019-08-02 |
아뮤닉스 파마슈티컬스, 인크. |
Glucagon-like peptide-2 compositions and methods of making and using same
|
EP3597764A3
(en)
|
2012-02-01 |
2020-05-06 |
SGI-DNA, Inc. |
Material and methods for the synthesis of error-minimized nucleic acid molecules
|
SG11201403988WA
(en)
|
2012-02-09 |
2014-10-30 |
Var2 Pharmaceuticals Aps |
Targeting of chondroitin sulfate glycans
|
PL3564260T3
(en)
|
2012-02-15 |
2023-03-06 |
Bioverativ Therapeutics Inc. |
Factor viii compositions and methods of making and using same
|
HUE043537T2
(en)
|
2012-02-15 |
2019-08-28 |
Bioverativ Therapeutics Inc |
Recombinant factor viii proteins
|
US9932565B2
(en)
|
2012-07-31 |
2018-04-03 |
Bioasis Technologies, Inc. |
Dephosphorylated lysosomal storage disease proteins and methods of use thereof
|
US20150307865A1
(en)
|
2012-10-15 |
2015-10-29 |
Novo Nordisk Health Care Ag |
Coagulation factor vii polypeptides
|
BR112015022416A2
(en)
|
2013-03-13 |
2017-10-24 |
Bioasis Technologies Inc |
p97 fragments and their uses
|
WO2014153258A2
(en)
|
2013-03-14 |
2014-09-25 |
Epeius Biotechnologies Corporation |
Improved thymidine kinase gene
|
WO2014202089A2
(en)
|
2013-06-18 |
2014-12-24 |
Roskilde Universitet |
Variants of anti-freeze polypeptides
|
TW202003554A
(en)
|
2013-08-14 |
2020-01-16 |
美商百歐維拉提夫治療公司 |
Factor VIII-XTEN fusions and uses thereof
|
CA2935195A1
(en)
|
2014-02-03 |
2015-08-06 |
Bioasis Technologies, Inc. |
P97 fusion proteins
|
WO2015126729A1
(en)
|
2014-02-19 |
2015-08-27 |
Bioasis Technologies, Inc. |
P97-ids fusion proteins
|
US20170136102A1
(en)
|
2014-03-27 |
2017-05-18 |
Umender Kumar SHARMA |
Phage-derived compositions for improved mycobacterial therapy
|
CN106413757B
(en)
|
2014-05-01 |
2022-01-14 |
比奥阿赛斯技术有限公司 |
P97-Polynucleotide conjugates
|
BR112018002150A2
(en)
|
2015-08-03 |
2018-09-18 |
Bioverativ Therapeutics Inc |
factor ix fusion proteins and methods of manufacturing and using them
|
CN107969127B
(en)
|
2015-09-08 |
2022-09-06 |
赛瑞品股份有限公司 |
APOA-1 fusion polypeptides and related compositions and methods
|
WO2018136163A2
(en)
|
2016-12-09 |
2018-07-26 |
Theripion, Inc. |
Tandem apoa-1 fusion polypeptides
|
JP7227162B2
(en)
|
2017-06-06 |
2023-02-21 |
ザイマージェン インコーポレイテッド |
HTP Genome Engineering Platform for Improving Fungal Strains
|
BR112020001180A2
(en)
|
2017-07-20 |
2020-09-08 |
Aptevo Research And Development Llc |
antigen-binding proteins that bind to 5t4 and 4-1bb and related compositions and methods
|
EP3710484B1
(en)
|
2017-12-20 |
2023-10-25 |
Harbour Biomed (Shanghai) Co., Ltd |
Antibodies binding ctla-4 and uses thereof
|
US10150801B1
(en)
|
2017-12-27 |
2018-12-11 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
AU2017444998A1
(en)
|
2017-12-27 |
2020-05-28 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
EP3810750A4
(en)
|
2018-06-06 |
2022-03-23 |
Zymergen, Inc. |
Manipulation of genes involved in signal transduction to control fungal morphology during fermentation and production
|
WO2020012021A1
(en)
|
2018-07-13 |
2020-01-16 |
Varct Diagnostics Aps |
Isolation of circulating cells of fetal origin using recombinant malaria protein var2csa
|
EP4021512A1
(en)
|
2019-08-26 |
2022-07-06 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
US10675332B1
(en)
|
2019-08-26 |
2020-06-09 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and methods of use thereof
|
WO2021262081A1
(en)
|
2020-06-22 |
2021-12-30 |
Imunami Laboratories Pte. Ltd. |
Recombinant polypeptides and combinations for use in the treatment of cancer
|
US11479779B2
(en)
|
2020-07-31 |
2022-10-25 |
Zymergen Inc. |
Systems and methods for high-throughput automated strain generation for non-sporulating fungi
|
WO2022178078A1
(en)
|
2021-02-19 |
2022-08-25 |
Theripion, Inc. |
Paraoxonase fusion polypeptides and related compositions and methods
|